Elsevier

The Lancet

Volume 343, Issue 8908, 21 May 1994, Pages 1260-1261
The Lancet

Short reports
Active or recent parvovirus B19 infection in children with Kawasaki disease

https://doi.org/10.1016/S0140-6736(94)92154-7Get rights and content

Abstract

Because parvovirus B19 occasionally causes some of the features typical of Kawasaki disease, we investigated B19 involvement in 15 children with Kawasaki disease. Active or recent B19 infection, as shown by B19-DNAaemia, positive B19-specific IgM antibodies, or both, was diagnosed in 10 patients (67%). A high frequency of all major criteria for diagnosis of Kawasaki disease (60%), anaemia (60%), coronary aneurysms (30%), and arthropathy (30%) was found in children with B19-associated Kawasaki disease. Thus B19 may have a pathogenic role in the development of Kawasaki disease, with other predisposing factors.

References (10)

There are more references available in the full text version of this article.

Cited by (143)

  • Developmental and Inherited Liver Disease

    2023, MacSween's Pathology of the Liver, Eighth Edition
  • Parvovirus B19 infections in adults

    2022, Revue de Medecine Interne
  • Developmental and Inherited Liver Disease

    2018, MacSween's Pathology of the Liver
  • Kawasaki disease – A common childhood vasculitis

    2015, Indian Journal of Rheumatology
    Citation Excerpt :

    A host of infectious agents have been ‘linked’ with KD or incriminated in the pathogenesis of the disease. These include coronavirus,19 parvovirus,20 Staphylococcus aureus,21 Epstein–Barr virus,22 chlamydia23 and mycobacteria.24 Staphylococcal and streptococcal superantigens have been hypothesized as triggering agents in the cascade of KD.1

  • Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses

    2015, Journal of Clinical Virology
    Citation Excerpt :

    This data hypothesize that PVB19 (auto-) immunity can induce/involve CD4+ T cells with strong cytolytic potential (Natural Killer cells CD56 surface marker, expression of cytolytic proteins…) and suggest that such cells could function within both immune regulation and triggering of autoimmune phenomena such as systemic lupus erythematosus or rheumatoid arthritis [19]. Data published in the literature over the last 20 years suggest that PVB19 could be involved in the induction or pathogenesis of numerous systemic autoimmune diseases including: Adult-onset Still’s disease, Dermatomyositis, Sjögren syndrome, Systemic scleroderma, Giant cell arteritis (temporal arteritis), Henoch–Schönlein purpura, Granulomatosis with polyangiitis, Kawasaki disease and Polyarteritis nodosa [20–57]. However, these numerous articles (essentially on the basis of case reports or limited patient series) were insufficient to establish a definite relationship between PVB19 infection and these pathologies.

View all citing articles on Scopus
View full text